Literature DB >> 18555662

Regulation of pro-apoptotic BH3-only proteins and its contribution to cancer progression and chemoresistance.

Jose L Fernandez-Luna1.   

Abstract

The BH3-only members of the Bcl-2 protein family function as damage sensors in the cell and initiate the apoptotic cascade. Apoptosis is the primary mechanism by which the body gets rid of genetically defective cells and is critical for preventing the accumulation of cells with tumorigenic potential. BH3-only proteins have evolved to respond to distinct forms of cellular stress or DNA damage by inactivating the protective function of the prosurvival members of the Bcl-2 family. Therefore, a downregulated expression or activity of these proteins may favour tumor development. Moreover, the pro-apoptotic proteins are required for the success of most cancer treatments, including chemotherapy. Resistance to chemotherapy, a common feature of cancer, often reflects an inability of tumor cells to undergo apoptosis. Deciphering the regulation and activity of the BH3-only proteins may provide the basis for novel therapeutic strategies aimed at promoting tumor cell death or enhancing susceptibility to chemotherapeutic agents. This review summarizes the current knowledge of BH3-only proteins and their contribution to tumorigenesis and chemoresistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555662     DOI: 10.1016/j.cellsig.2008.04.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  12 in total

1.  Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.

Authors:  Lara Grande; Gabriel Bretones; Manuel Rosa-Garrido; Eva M Garrido-Martin; Teresa Hernandez; Susana Fraile; Luisa Botella; Enrique de Alava; August Vidal; Xavier Garcia del Muro; Alberto Villanueva; M Dolores Delgado; Jose L Fernandez-Luna
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

2.  SIRT1 deficiency downregulates PTEN/JNK/FOXO1 pathway to block reactive oxygen species-induced apoptosis in mouse embryonic stem cells.

Authors:  Hee-Don Chae; Hal E Broxmeyer
Journal:  Stem Cells Dev       Date:  2011-01-03       Impact factor: 3.272

Review 3.  BH3-only proteins in apoptosis and beyond: an overview.

Authors:  E Lomonosova; G Chinnadurai
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

4.  Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.

Authors:  Tao Wang; Zi Liu; Fan Shi; Jiquan Wang
Journal:  Mol Cell Biochem       Date:  2016-01-28       Impact factor: 3.396

5.  Characterization of a novel interaction between Bcl-2 members Diva and Harakiri.

Authors:  Lorenzo Sborgi; Susana Barrera-Vilarmau; Patricia Obregón; Eva de Alba
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

6.  E2F-1- and E2Ftr-mediated apoptosis: the role of DREAM and HRK.

Authors:  Hongying Hao; Canming Chen; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; H Sam Zhou; Kelly M McMasters
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

7.  Apoptotic machinery diversity in multiple myeloma molecular subtypes.

Authors:  Patricia Gomez-Bougie; Martine Amiot
Journal:  Front Immunol       Date:  2013-12-23       Impact factor: 7.561

8.  PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer.

Authors:  Wenbin Li; Yue Zhu; Kelin Zhang; Xianhuan Yu; Haoming Lin; Wenrui Wu; Yaorong Peng; Jian Sun
Journal:  Exp Mol Med       Date:  2020-03-02       Impact factor: 8.718

9.  Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells.

Authors:  Martin Michaelis; Denise Klassert; Susanne Barth; Tatyana Suhan; Rainer Breitling; Bernd Mayer; Nora Hinsch; Hans W Doerr; Jaroslav Cinatl; Jindrich Cinatl
Journal:  Mol Cancer       Date:  2009-09-29       Impact factor: 27.401

10.  Targeted expression of BikDD combined with metronomic doxorubicin induces synergistic antitumor effect through Bax activation in hepatocellular carcinoma.

Authors:  Huei-Yue Dai; Hui-Yu Chen; Wei-Chen Lai; Mien-Chie Hung; Long-Yuan Li
Journal:  Oncotarget       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.